CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 Genetic Test sale cost 4400 AED
CLCNKB Gene Bartter Syndrome Type 3 Genetic Test sale cost 4400 AED CLCNKB Gene Bartter Syndrome Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
STAT5B Gene Growth Hormone Insensitivity with Immunodeficiency Genetic Test sale cost 4400 AED STAT5B Gene Growth Hormone Insensitivity with Immunodeficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 Genetic Test” is a specialized diagnostic assessment available at DNA Labs UAE, aimed at detecting mutations in the CRB2 gene, which are linked to Focal Segmental Glomerulosclerosis (FSGS) Type 9. FSGS is a disease that affects the kidney’s filtering units, leading to severe renal impairment and, in many cases, chronic kidney disease. The CRB2 gene plays a crucial role in the development and functioning of podocytes, cells essential for the kidney’s filtering mechanism. Mutations in this gene can disrupt podocyte function, leading to the characteristic scarring observed in FSGS.

This genetic test is crucial for individuals who have a family history of FSGS or exhibit symptoms related to kidney dysfunction, as early detection can significantly influence the management and prognosis of the condition. By precisely identifying the genetic mutation, healthcare providers can tailor treatment strategies to the patient’s specific needs, potentially slowing the progression of the disease and preserving kidney function for as long as possible.

The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the assessment and the sophisticated technology employed in the analysis. For patients and families facing the challenges of FSGS, this test represents a critical step in understanding their condition and navigating the path towards optimal care and treatment.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CRB2 Gene Focal segmental glomerulosclerosis type 9 Genetic Test

Welcome to DNA Labs UAE, where we offer the CRB2 Gene Focal segmental glomerulosclerosis type 9 Genetic Test. This test is designed to diagnose and provide valuable information for the treatment and management of FSGS type 9.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Hepatology Nephrology Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CRB2 Gene Focal segmental glomerulosclerosis type 9 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the CRB2 Gene Focal segmental glomerulosclerosis type 9 NGS Genetic DNA Test gene CRB2.

Test Details

The CRB2 gene is associated with focal segmental glomerulosclerosis (FSGS) type 9, a kidney disorder that affects the glomeruli. The glomeruli are responsible for filtering waste and excess fluid from the blood. Next-generation sequencing (NGS) technology is used to analyze a person’s DNA in order to identify any mutations or changes in the CRB2 gene that may be causing the condition. This genetic testing can help diagnose FSGS type 9, determine the specific genetic mutation causing it, and provide valuable information for treatment and management of the disease. It can also be useful for identifying other family members who may be at risk of developing FSGS type 9.

Test Name CRB2 Gene Focal segmental glomerulosclerosis type 9 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CRB2 Gene Focal segmental glomerulosclerosis type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CRB2 Gene Focal segmental glomerulosclerosis type 9 NGS Genetic DNA Test gene CRB2
Test Details

The CRB2 gene is associated with a condition called focal segmental glomerulosclerosis (FSGS) type 9. FSGS is a kidney disorder that affects the glomeruli, which are tiny structures in the kidneys responsible for filtering waste and excess fluid from the blood.

NGS stands for next-generation sequencing, which is a technique used to analyze a person’s DNA. In the context of genetic testing for FSGS type 9, NGS can be used to identify any mutations or changes in the CRB2 gene that may be causing the condition.

Genetic testing for FSGS type 9 using NGS can help diagnose the condition, determine the specific genetic mutation causing it, and provide valuable information for treatment and management of the disease. It can also be useful for identifying other family members who may be at risk of developing FSGS type 9.

SKU: TEST-3623 Category:

Related products